“Two-birds-one-stone” oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment
Science Advances · 26.07.2024 · 10 (30)
DOI: 10.1126/sciadv.ado7438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 26.07.2024. Verfasst von Long Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Oxidation-Reduction, Homeostasis, Colitis, Ulcerative, Nanoparticles. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Designing highly efficient orally administrated nanotherapeutics with specific inflammatory site–targeting functions in the gastrointestinal tract for ulcerative colitis (UC) management is a noteworthy challenge. Here, we focused on exploring a specific targeting oral nanotherapy, serving as “one stone,” for the directed localization of inflammation and the regulation of redox homeostasis, thereby achieving effects against “two birds” for UC treatment. Our designed nanotherapeutic agent OPNs@LMWH (oxidation-sensitive ε-polylysine nanoparticles at low–molecular weight heparin) exhibited specific active targeting effects and therapeutic efficacy simultaneously. Our results indicate that OPNs@LMWH had high integrin αM–mediated immune cellular uptake efficiency and preferentially accumulated in inflamed tissues. We also confirmed its effectiveness in the treatment experiment of colitis in mice by ameliorating oxidative stress and inhibiting the activation of inflammation-associated signaling pathways while simultaneously bolstering the protective mechanisms of the colonic epithelium. Overall, these findings underscore the compelling dual functionalities of OPNs@LMWH, which enable effective oral delivery to inflamed sites, thereby facilitating precise UC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.
- Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518118, China.
- Center for Synthetic and Systems Biology, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Long Huang, Qin Xuan Zhou, Can Yang Zhang, Yi Wang, Xin-Hui Xing
Zitieren
APA
Huang, L., Hu, W., Huang, L. Q., Zhou, Q. X., Song, Z. Y., Tao, H. Y., Xu, B., Zhang, C. Y., Wang, Y., & Xing, X. H. (2024). “Two-birds-one-stone” oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment. Science Advances, 10(30). https://doi.org/10.1126/sciadv.ado7438
Vancouver
Huang L, Hu W, Huang LQ, Zhou QX, Song ZY, Tao HY, et al. “Two-birds-one-stone” oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment. Science Advances. 2024;10(30). doi:10.1126/sciadv.ado7438
BibTeX
@article{Huang2024,
author = {Huang, Long and Hu, Wei and Huang, Long Qun and Zhou, Qin Xuan and Song, Zheng Yang and Tao, Heng Yu and Xu, Bing and Zhang, Can Yang and Wang, Yi and Xing, Xin-Hui},
title = {“Two-birds-one-stone” oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {30},
doi = {10.1126/sciadv.ado7438}
}
EUVIMED